These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks. Leavitt BR; Kordasiewicz HB; Schobel SA JAMA Neurol; 2020 Jun; 77(6):764-772. PubMed ID: 32202594 [TBL] [Abstract][Full Text] [Related]
16. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
18. Towards a transgenic model of Huntington's disease in a non-human primate. Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016 [TBL] [Abstract][Full Text] [Related]